Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells

被引：56

作者：

Bontkes, Hetty J. ^{[1
]}

Kramer, Duco ^{[1
]}

Ruizendaal, Janneke J. ^{[1
]}

Meijer, Chris J. L. M. ^{[1
]}

Hooijberg, Erik ^{[1
]}

机构：

[1] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands

来源：

CLINICAL IMMUNOLOGY | 2008年 / 127卷 / 03期

关键词：

human; dendritic cells; natural killer cells; cytokines; vaccination;

D O I：

10.1016/j.clim.2008.02.001

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Immunotherapy aiming at the combined activation of tumor associated antigen (TAA) specific cytotoxic T lymphocytes (CTL) and Natural Killer (NK) cells may be crucial to eradicate both MHC-I positive and negative tumors. Vaccination with mature dendritic cells (DC) transfected with mRNA encoding for TAA and the pro-inflammatory cytokines interteukin (IL)-12 and IL-18 may increase NK cell and TAA specific CTL activity. We demonstrate here that IL-12 over-expressing human DC induces increased NK cell activation and effector function and confirm the increase in TAA specific CTL by TAA/IL-12 double transfected DC. The effects of IL-18 transfection were limited to phenotypic activation and down-regulation of tissue homing receptors and did not add to the effect of IL-12 on NK cell effector function. In conclusion, co-transfection of TAA and IL-12 mRNA into mature DCs offers a vaccine for the induction of an antitumor immune response mediated by CTL and NK effector cells. (c) 2008 Elsevier Inc. All rights reserved.

引用

页码：375 / 384

页数：10

共 38 条

[31]

Tanaka F, 2000, CANCER RES, V60, P4838

[32] Identification of CARDIAK, a RIP-like kinase that associates with caspase-1 [J].

Thome, M ;

Hofmann, K ;

Burns, K ;

Martinon, F ;

Bodmer, JL ;

Mattmann, C ;

Tschopp, J .

CURRENT BIOLOGY, 1998, 8 (15) :885-888

[33] CXCL8 secretion by dendritic cells predicts contact allergens from irritants [J].

Toebak, MJ ;

Pohlmann, PR ;

Sampat-Sardjoepersad, SC ;

von Blomberg, BME ;

Bruynzeel, DP ;

Scheper, RJ ;

Rustemeyer, T ;

Gibbs, S .

TOXICOLOGY IN VITRO, 2006, 20 (01) :117-124

[34] Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells [J].

Van Tendeloo, VFI ;

Ponsaerts, P ;

Lardon, F ;

Nijs, G ;

Lenjou, M ;

Van Broeckhoven, C ;

Van Bockstaele, DR ;

Berneman, ZN .

BLOOD, 2001, 98 (01) :49-56

[35] Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction [J].

Vieira, PL ;

de Jong, EC ;

Wierenga, EA ;

Kapsenberg, ML ;

Kalinski, P .

JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4507-4512

[36] IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro [J].

Vujanovic, L. ;

Ranieri, E. ;

Gambotto, A. ;

Olson, W. C. ;

Kirkwood, J. M. ;

Storkus, W. J. .

CANCER GENE THERAPY, 2006, 13 (08) :798-805

[37] The role of natural killer cells in tumor control - effectors and regulators of adaptive immunity [J].

Wallace, ME ;

Smyth, MJ .

SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 27 (01) :49-64

[38]

Yoshimoto T, 1998, J IMMUNOL, V161, P3400

← 1 2 3 4 →